Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  F-18 16 alpha-fluoroestradiol
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-8 of 8 for your search:
Start Over
F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer
Phase: Phase II
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00270, IRB #6590, CDR0000584077, UWCC-6590, 8052, 6590, NCT00602043
Molecular Imaging of Fulvestrant Effects on Availability of ER Binding Sites
Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: RUG2010-2611, NCT01377324
FES-PET to Determine ER-expression in Epithelial Ovarian Cancer
Phase: Phase II
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: RUG2011-0704, NCT01439490
PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 6213, P30CA015704, UWCC-6213, UWCC-06-0445-H/D, CDR0000492255, NCT00362973
Positron Emission Tomography (PET) Using Hormone Receptor Ligands in Breast Cancer
Phase: No phase specified
Type: Diagnostic
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 05-088, NCT00647790
Imaging of ER Density to Guide and Improve Tailored Therapy for Acquired Anti-hormonal Resistant Breast Cancer
Phase: No phase specified
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: RUG 2009-4529, NCT01088477
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 6856, NCI-2010-01289, NCT01153672
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 7841, NCI-2012-02004, P30CA015704, NCT01720602
Start Over